STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $2.1M priced
What the filings say about CVCO
Insiders, 180 days
-$2.3M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$224.6K
2 notices
Cavco Industries insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CAVCO INDUSTRIES, INC. insiders sold a net $2.3M of stock across 69 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CVCO planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
BIGBEE PAUL
Filed 2026-08-17
$207.6K
LISA DANIELS
Filed 2026-07-30
$17.0K
ALLISON ADEN
Filed 2026-06-25
$900.9K
Executive pay vs shareholder return · Mr. Boor
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.0M
$4.1M
$1.9M
+101%
+28%
2024
$7.6M
$15.0M
$1.9M
+121%
+36%
2023
$4.5M
$6.1M
$1.4M
+72%
+67%
2022
$5.4M
$8.0M
$1.7M
+37%
+1%
2021
$4.7M
$4.5M
$1.1M
+5%
-14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.3M sold by insiders over 180 days, $224.6K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.3B
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM CVCO
FY Mar 2026
$2.2B
FY Mar 2025
$2.0B
FY Mar 2024
$1.8B
FY Apr 2023
$2.1B
FY Apr 2022
$1.6B
Jun 2026
$610.0M
Mar 2026
$550.1M
Dec 2025
$581.0M
Sep 2025
$556.5M
Jun 2025
$556.9M
Mar 2025
$508.4M
Dec 2024
$522.0M
Sep 2024
$507.5M
At each fiscal year end
Single quarter
Net margin, TTM
+7.9%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM CVCO
FY Mar 2026
+8.5%
FY Mar 2025
+8.5%
FY Mar 2024
+8.8%
FY Apr 2023
+11.2%
FY Apr 2022
+12.2%
Jun 2026
+6.9%
Mar 2026
+7.8%
Dec 2025
+7.6%
Sep 2025
+9.4%
Jun 2025
+9.3%
Mar 2025
+7.1%
Dec 2024
+10.8%
Sep 2024
+8.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
$234.7M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM CVCO
FY Mar 2026
$232.1M
FY Mar 2025
$157.1M
FY Mar 2024
$207.3M
FY Apr 2023
$211.6M
FY Apr 2022
$125.6M
Jun 2026
$49.0M
Mar 2026
$59.3M
Dec 2025
$57.6M
Sep 2025
$68.7M
Jun 2025
$46.4M
Mar 2025
$32.5M
Dec 2024
$32.3M
Sep 2024
$49.8M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity CVCO
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
n/a
FY Apr 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt CVCO
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
n/a
FY Apr 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.7%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity CVCO
FY Mar 2026
+17.6%
FY Mar 2025
+16.3%
FY Mar 2024
+15.7%
FY Apr 2023
+26.7%
FY Apr 2022
+26.1%
Jun 2026
+16.7%
Mar 2026
+17.6%
Dec 2025
+17.2%
Sep 2025
+18.5%
Jun 2025
+17.9%
Mar 2025
+16.3%
Dec 2024
+16.3%
Sep 2024
+14.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+12.3%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets CVCO
FY Mar 2026
+13.2%
FY Mar 2025
+12.4%
FY Mar 2024
+11.9%
FY Apr 2023
+19.6%
FY Apr 2022
+18.8%
Jun 2026
+12.3%
Mar 2026
+13.2%
Dec 2025
+12.9%
Sep 2025
+13.8%
Jun 2025
+13.4%
Mar 2025
+12.4%
Dec 2024
+12.4%
Sep 2024
+10.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital CVCO
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
n/a
FY Apr 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+19.5%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed CVCO
FY Mar 2026
+20.2%
FY Mar 2025
+17.4%
FY Mar 2024
+17.1%
FY Apr 2023
+31.6%
FY Apr 2022
+25.7%
Jun 2026
+19.5%
Mar 2026
+20.2%
Dec 2025
+19.2%
Sep 2025
+20.3%
Jun 2025
+19.4%
Mar 2025
+17.4%
Dec 2024
+17.6%
Sep 2024
+15.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
23.12x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing CVCO
FY Mar 2026
19.44x
FY Mar 2025
24.77x
FY Mar 2024
21.75x
FY Apr 2023
11.79x
FY Apr 2022
11.42x
Jun 2026
26.89x
Mar 2026
19.44x
Dec 2025
26.09x
Sep 2025
23.53x
Jun 2025
18.66x
Mar 2025
24.77x
Dec 2024
21.82x
Sep 2024
24.41x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value CVCO
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
n/a
FY Apr 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield CVCO
FY Mar 2026
+6.4%
FY Mar 2025
+3.8%
FY Mar 2024
+6.2%
FY Apr 2023
+7.7%
FY Apr 2022
+5.6%
Jun 2026
+4.9%
Mar 2026
+6.4%
Dec 2025
+4.4%
Sep 2025
+4.0%
Jun 2025
+4.7%
Mar 2025
+3.8%
Dec 2024
+3.9%
Sep 2024
+4.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -0%, PEG needs growth
PEG, trailing CVCO
FY Mar 2026
1.25x
FY Mar 2025
1.89x
FY Mar 2024
n/a
FY Apr 2023
0.45x
FY Apr 2022
0.07x
Jun 2026
n/a
Mar 2026
1.25x
Dec 2025
1.97x
Sep 2025
0.63x
Jun 2025
0.54x
Mar 2025
1.89x
Dec 2024
7.17x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CVCO ranks highest on risk and compliance (85th percentile) and profitability (83rd), and lowest on insider conviction (10th), among Materials peers.
Profitability
83
Inputs
Return on equity+16.7% · 77 pct, sector of 100
Return on assets+12.3% · 89 pct, sector of 120
Return on invested capitalno debt line filed
Return on capital employed+19.5% · 84 pct, sector of 96
Growth
79
Inputs
Revenue growth, YoY+11.4% · 79 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
10
Inputs
Net Form 4 buying (codes P and S), 180d-$2.3M · 20 pct, sector of 80
Insider buyers, 180d0 · 0 pct, sector of 80
Risk and compliance
85
Inputs
Short interest, % of float+4.5% · 54 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+0.3% · 100 pct, sector of 111
3 not measured: Financial health, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CVCO filings, in plain words
Are Cavco Industries insiders buying or selling CVCO?
In the 180 days to 2026-10-28, Cavco Industries insiders were net sellers, a net $2.3M across purchases and sales reported on Form 4, by 5 sellers.
Are there planned insider sales of CVCO?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $224.6K of stock; the latest, by BIGBEE PAUL, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, Cavco Industries insiders were net sellers of CVCO, a net $2.3M across purchases and sales reported on Form 4 by 5 sellers. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $224.6K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.